The ANCA PR3 test detects antibodies against proteinase 3 (PR3) in serum, which are commonly associated with certain autoimmune vasculitic disorders. It plays a crucial role in the diagnosis and monitoring of conditions such as granulomatosis with polyangiitis. Measuring PR3-ANCA levels helps clinicians assess disease activity and guide treatment decisions. Metropolis Healthcare provides this serum-based immunological test with precise methodologies and stringent quality assurance for reliable clinical interpretation.
Price:
Rs. 1,700.00
Sample Type: SERUM
Fasting Not Required
Notes: P0081
Frequently Asked Questions (FAQ's):
What does the ANCA PR3 test detect?
The ANCA PR3 test detects antibodies directed against proteinase 3 in serum, which Metropolis Healthcare uses to support the diagnosis of autoimmune vasculitis.
How does Metropolis Healthcare perform the ANCA PR3 test?
Metropolis Healthcare performs this test using standardized immunoassay techniques to ensure accurate and reproducible results.
Who should undergo the ANCA PR3, SERUM test?
This test is recommended for individuals with symptoms suggestive of systemic vasculitis, unexplained inflammation, or suspected granulomatosis with polyangiitis.
Why is the ANCA PR3 test important in clinical practice?
At Metropolis Healthcare, this test helps clinicians confirm diagnosis, evaluate disease severity, and monitor response to immunosuppressive therapy.
How is the serum sample collected for the ANCA PR3 test at Metropolis Healthcare?
A blood sample is collected by trained Metropolis Healthcare professionals, and serum is processed following strict laboratory protocols.
Can Metropolis Healthcare use this test for disease monitoring?
Yes, PR3-ANCA levels measured at Metropolis Healthcare can help track disease activity and treatment effectiveness over time.
Is the ANCA PR3 test used along with other investigations?
Metropolis Healthcare may recommend this test alongside other ANCA assays and clinical evaluations for comprehensive autoimmune assessment.